Tirzepatide: A Different Approach While semaglutide is a GLP-1 receptor agonist, other medications like Mounjaro and Zepbound (which contain the active ingredient Tirzepatide) work on two different hormone receptors: GLP-1 and GIP (glucose-dependent insulinotropic polypeptide)
Our clear backing design prevents tearing and ensures easy application unlike other brands with fragile paper backings that can damage the patch
Anti-inflammatory effects of GLP-1 receptor activation in the brain in neurodegenerative diseases
Retrieved from He, L., Wang, J., Ping, F., et al
Research shows these effects make the compound a useful tool for muscle recovery and metabolic adaptation studies
Treats Hypoactive Sexual Desire Disorder (HSDD) The FDA approved the brand version of bremelanotide (Vyleesi) in 2019 for the treatment of generalized acquired hypoactive sexual desire disorder (HSDD) in premenopausal females